The Donald Trump administration has provided $2.9 million to aid India's fight against the coronavirus disease.
In an official statement issued by United States (US) Embassy in New Delhi on Monday (6 April), the US government said that the pandemic financial support was granted to India through the US Agency for International Development (USAID).
The relief is in addition to $1.4 billion in health assistance, and nearly $3 billion in total assistance, that the US has provided to India over the last 20 years, the embassy said.
The statement comes a day after President Trump called Prime Minister Narendra Modi, requesting him to supply the anti-malaria drug hydroxychloroquine that is being used to treat Covid-19 patients and as prophylactic by health care workers. The government has imposed a ban on export of the drug since the coronavirus outbreak hit India.
The US as of now has the highest number of the novel coronavirus infection cases in the world. On Monday, with over 337,000 cases of infections, the US was nearing 10,000 deaths. Relatively, India has managed to contain the pandemic with 118 deaths and over 4,300 cases of infections.
The Modi government is expected to take a call on the request after assessing India's domestic requirement of the drug.
The Covid-19 aid to India will support two organisations, the official statement said. $2.4 million will be used for USAID's health strengthening project, implemented by Jhpiego, an international non-profit health organisation affiliated with Johns Hopkins University, and $500,000 for the World Health Organisation (WHO). The funds will help the Indian government to slow the spread of Covid-19, provide care for the affected, and support local communities with the tools needed to contain the disease, the US said.
Praising India's efforts, US Ambassador to India Kenneth Juster said, "The US government, through USAID, the Centres for Disease Control and Prevention, and other US Department of Health and Human Services agencies, is working closely with the Government of India and multilateral agencies to support India''s response to this global pandemic."
(This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.)
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.